← back to search

Marijke Peetermans

General Department of Preventive Medicine · BE
Area of research
Infectious Diseases · Public Health, Environmental and Occupational Health
Research interest
Research interests include Antimicrobial Resistance in Staphylococcus, Antifungal resistance and susceptibility, Streptococcal Infections and Treatments, and Infective Endocarditis Diagnosis and Management.
h-index
27
citations
2,313
works
101
NIH funding
primary concept
Medicine
email

Recent publications

Outcomes of transplant recipients on ECMO for COVID-19 respiratory failure: an ELSO registry study
Critical Care 2025cited by 2position: firstdoi
Personalized mechanical ventilation guided by lung ultrasound in patients with ARDS: a pilot phase of a randomized clinical trial
Intensive Care Medicine Experimental 2025cited by 0position: middledoi
Clinical and molecular epidemiological features of critically ill patients with invasive group A Streptococcus infections: a Belgian multicenter case-series
Annals of Intensive Care 2024cited by 37position: firstdoi
Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective, observational study
The Lancet Microbe 2024cited by 28position: middledoi
Profiling Bacteria in the Lungs of Patients with Severe Influenza Versus COVID-19 with or without Aspergillosis
American Journal of Respiratory and Critical Care Medicine 2024cited by 14position: middledoi
A Pathology-based Case Series of Influenza- and COVID-19–associated Pulmonary Aspergillosis: The Proof Is in the Tissue
American Journal of Respiratory and Critical Care Medicine 2023cited by 54position: middledoi
High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation
Clinical Infectious Diseases 2023cited by 51position: middledoi
Impact of BMI on outcomes in respiratory ECMO: an ELSO registry study
Intensive Care Medicine 2022cited by 51position: firstdoi
Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb
Cell 2021cited by 387position: middledoi
Intensive care unit acquired muscle weakness in COVID-19 patients
Intensive Care Medicine 2020cited by 151position: middledoi
Necrotizing skin and soft-tissue infections in the intensive care unit
Clinical Microbiology and Infection 2019cited by 179position: firstdoi
<i>Staphylococcus aureus</i> endocarditis: distinct mechanisms of bacterial adhesion to damaged and inflamed heart valves
European Heart Journal 2019cited by 143position: middledoi
Von Willebrand factor and ADAMTS13 impact on the outcome of Staphylococcus aureus sepsis
Journal of Thrombosis and Haemostasis 2019cited by 44position: firstdoi
Clumping factor A, von Willebrand factor‐binding protein and von Willebrand factor anchor Staphylococcus aureus to the vessel wall
Journal of Thrombosis and Haemostasis 2017cited by 89position: middledoi
An open conformation of ADAMTS‐13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura
Journal of Thrombosis and Haemostasis 2017cited by 89position: middledoi
Shear-Resistant Binding to von Willebrand Factor Allows<i>Staphylococcus lugdunensis</i>to Adhere to the Cardiac Valves and Initiate Endocarditis
The Journal of Infectious Diseases 2016cited by 48position: middledoi
Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonists
Thrombosis Research 2015cited by 100position: lastdoi
Staphylokinase Control of<i>Staphylococcus aureus</i>Biofilm Formation and Detachment Through Host Plasminogen Activation
The Journal of Infectious Diseases 2015cited by 80position: middledoi
Coagulase Activity by Staphylococcus aureus: A Potential Target for Therapy?
Seminars in Thrombosis and Hemostasis 2015cited by 57position: lastdoi
The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disorders
Journal of Thrombosis and Haemostasis 2015cited by 37position: middledoi
Adhesion of Staphylococcus aureus to the vessel wall under flow is mediated by von Willebrand factor–binding protein
Blood 2014cited by 117position: middledoi
Plasminogen activation by staphylokinase enhances local spreading of S. aureus in skin infections
BMC Microbiology 2014cited by 55position: firstdoi
Monitoring and reversal strategies for new oral anticoagulants
Expert Review of Cardiovascular Therapy 2014cited by 37position: middledoi
The Role of Staphylothrombin-Mediated Fibrin Deposition in Catheter-Related Staphylococcus aureus Infections
The Journal of Infectious Diseases 2013cited by 59position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Peter Verhamme · Hospital Universitario La Paz13 papers (2013–2019)Thomas Vanassche · KU Leuven11 papers (2013–2019)Marc Hoylaerts · KU Leuven7 papers (2013–2019)Laurens Liesenborghs · Research Institute for Tropical Medicine7 papers (2014–2019)Greet Hermans · KU Leuven5 papers (2022–2025)Jorien Claes · KU Leuven5 papers (2014–2019)Joost Wauters · KU Leuven5 papers (2022–2025)Philippe Meersseman · KU Leuven5 papers (2022–2025)Olaf Schneewind · University of Chicago4 papers (2013–2019)Dominique Missiakas · Howard University4 papers (2013–2019)Christophe Vandenbriele · Guy's and St Thomas' NHS Foundation Trust4 papers (2014–2023)Alexander Wilmer · KU Leuven3 papers (2022–2023)Karen Vanhoorelbeke · Utrecht University3 papers (2014–2019)Yves Debaveye · KU Leuven3 papers (2023–2024)Marleen Lox · KU Leuven3 papers (2016–2019)Willy Peetermans · KU Leuven3 papers (2013–2019)Greetje Vande Velde · KU Leuven3 papers (2014–2023)Bart Meyns · KU Leuven2 papers (2022–2025)Katrien Lagrou · Bipar2 papers (2023–2023)Simon Feys · KU Leuven2 papers (2023–2023)